The interplay of metabolic dysfunction-associated fatty liver disease and viral hepatitis on liver disease severity: A large community-based study in a viral endemic area.
Chung-Feng HuangPo-Cheng LiangPei-Chien TsaiYu-Ju WeiChing-I HuangChih-Wen WangTyng-Yuang JangMing-Lun YehPo-Yau HsuMing-Yen HsiehYi-Hung LinChia-Yen DaiWan-Long ChuangJee-Fu HuangMing-Lung YuPublished in: Journal of gastroenterology and hepatology (2023)
MAFLD patients with diabetes and metabolic dysregulation had a higher risk of advanced liver disease. The effect was more significant in non-viral hepatitis subjects in a community level.